Claims for Patent: 12,233,049

Summary for Patent: 12,233,049

Title:	Stable pharmaceutical compositions of clonidine
Abstract:	The present invention relates to liquid pharmaceutical compositions of clonidine or its pharmaceutically acceptable salts thereof. Preferably, the liquid pharmaceutical compositions are suitable for oral administration, and are stable for extended periods of time. More specifically, stable liquid pharmaceutical compositions of clonidine at concentrations of 1 μg/mL or more are provided. The present invention further relates to stable oral liquid compositions of clonidine, methods for their administration, processes for their production, and use of these compositions for treatment of diseases treatable by clonidine.
Inventor(s):	Shailendra Mandge, Harish GUNDA, Naga Venkata Durga Prasad Ketha, Venkateshwar Reddy Keesara, Satheesh Balasubramanian, Sumitra Ashokkumar PILLAI
Assignee:	Azurity Pharmaceuticals Inc
Application Number:	US17/866,115
Patent Claims:	1. A liquid pharmaceutical composition having extended stability, said composition consisting of: (a) clonidine hydrochloride at a concentration of about 20 g/mL; (b) sodium chloride as a stabilizer at a concentration of about 2.5 mg/mL; (c) a preservative at a concentration of about 0.01% to 5.0%; (d) a sweetener at a concentration of about 0.20 mg/mL; (e) a flavoring agent at a concentration of about 0.20 mg/mL; and (f) water; and (g) optionally, a pH adjusting agent; wherein said composition is free of buffer; wherein said composition is contained in a multi-dose container; wherein said composition is an oral solution; and wherein not more than 2% w/w of total impurities are formed when said composition is stored for at least 6 months at 25° C./40% RH or 25° C./60% RH or 40° C./25% RH or 40° C./75% RH. 2. The composition of claim 1, wherein said composition has a pH in a range from about 4 to about 8. 3. The composition of claim 1, wherein said composition has a pH in a range from about 5 to about 6. 4. A liquid pharmaceutical composition having extended stability, said composition consisting of: (a) clonidine hydrochloride at a concentration of about 20 g/mL; (b) sodium chloride as a stabilizer at a concentration of about 2.5 mg/mL; (c) a preservative at a concentration of about 0.01% to 5.0%, wherein the preservative is potassium sorbate and/or sodium propionate; (d) a sweetener at a concentration of about 0.20 mg/mL; (e) a flavoring agent at a concentration of about 0.20 mg/mL; (f) water; (g) optionally, a pH adjusting agent; wherein said composition is free of buffer; wherein said composition is an oral solution; and wherein not more than 2% w/w of total impurities are formed when said composition is stored for at least 6 months at 25° C./40% RH or 25° C./60% RH or 40° C./25% RH or 40° C./75% RH. 5. The composition of claim 1, wherein said composition is provided in a polyethylene terephthalate (PET) bottle. 6. The composition of claim 1, wherein said composition is provided in a high-density polyethylene (HDPE) bottle. 7. The composition of claim 1, wherein said composition is provided in a glass bottle. 8. The composition of claim 1, wherein said composition exhibits in-use shelf life of at least one month when stored at room temperature. 9. The composition of claim 1, wherein the preservative is potassium sorbate. 10. The composition of claim 1, wherein the preservative is sodium propionate. 11. The composition of claim 1, wherein the sweetener is sucralose. 12. The composition of claim 1, wherein the pH is from about 3 to about 9. 13. The composition of claim 1, wherein the pH is from about 4 to about 6. 14. The composition of claim 4, wherein the preservative is potassium sorbate. 15. The composition of claim 4, wherein the preservative is sodium propionate. 16. The composition of claim 4, wherein the sweetener is sucralose. 17. The composition of claim 4, wherein the pH is from about 3 to about 9. 18. The composition of claim 4, wherein the pH is from about 4 to about 6. 19. The composition of claim 4, wherein the pH is from about 5 to about 6. 20. The composition of claim 4, wherein the pH is from about 4 to about 8. 21. The composition of claim 4, wherein the composition exhibits in-use shelf-life for at least one month when stored at room temperature. 22. The composition of claim 1, wherein the preservative is present at a concentration of 2.5 mg/mL. 23. The composition of claim 4, wherein the preservative is present at a concentration of 2.5 mg/mL.